Apply now to Health Hub 2020!

Do you have a start-up solving the following?: 1. Improving referral quality and treatment interventions for HF patients - 2. Improving collaborative clinical care decision making for MS patients. Apply before 13th April to join the next cohort of exciting HealthTech start-ups!

Gain access to Telefónica and Novartis global ecosystems

In 2019, we extended our partnership base to include Novartis (NYSE: NVS), the world’s 4th-largest pharmaceutical company with 2018 revenues of $52 billion. The programme has been rebranded as the Health Hub and has already on-boarded a cohort of three exceptional start-ups, including Virtue Health, which was founded by Rhodes Scholar and Oxford alumna Arfa Rehman.

What are the offerings from Novartis?

1. Access to the Novartis network

• A customised induction day tailored to the start-up’s growth needs at Novartis.

• Access to coaching and 1.1 engagements with Novartis subject matter experts from functions such as marketing, commercial, market access strategy, health economics and medical affairs.

• Access to a single-point of contact to provide support and guidance via a Strategic Partnership Lead.

2. Support with NHS engagement

• Understanding and navigating the NHS, to enhance knowledge and insights into the NHS.

• Accessing innovation masterclasses and associated programmes via the AHSN’s to enhance growth opportunities.

• Identifying senior NHS leaders as mentors and for 1.1 engagements for practical advice and guidance.

See all Health Hub alumni and a key success story from the 2019 cohort, below!

What we offer

World-class mentor board from Telefónica, Novartis and NHS

Telefónica business development support

Support in raising funds

Office space in Piccadilly Circus

Coaches that adapt to your needs

Cash investment

Access to the Wayra community of alumni, investors and corporate partners


No items found.
No items found.


No items found.



No items found.

TestCard Case Study

CONTEXT - Incorporated in May 2017 by Dr Andrew Botham and Luke Heron, TestCard’s solution is designed to solve the biggest issue confronting healthcare globally; isolation. Affordable, easy to use and precise, TestCard is able to significantly lower the cost of diagnosis and the monitoring of healthcare conditions whilst simultaneously improving the quality of results being delivered. TestCard joined the Health Hub in February 2019.
SOLUTION - Throughout the year, the Health Hub has put in place a tailored programme, including access to coaches, mentors and Novartis and Wayra's network. The programme's content included training and support over marketing, commercial, health economics and medical affairs. It also helped TestCard understanding and navigating the NHS.
RESULTS - TestCard has had an incredible year, awarded the ‘Top Emerging Technology’ prize at CES in Las Vegas and agreeing with NW London NHS to make its solution available to all 2.5m residents. Meanwhile, a successful pilot with one of the worlds largest pharmaceutical companies established that TestCard’s tech was more reliable than the fixed terminal scanners used in hospitals and clinics around the world, opening up a series of opportunities for collaboration

Areas of Interest

Cardio-Metabolic & Renal

1. Improving referral quality and treatment interventions for HF patients.

Digital solutions that can transform the current pathway of care for HF patients who require specialist clinical interventions.


2. Improving collaborative clinical care decision making for MS patients.

Digital solutions that can improve, automate and streamline the current MDT method for collaborative clinical care decision making.

Amazing, disruptive tech
Telefónica and Novartis fit


Health Hub 2020